Search
Lexeo Therapeutics Inc
LXEOAdd to Watchlist
4.690USD
+0.240+5.39%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
347.45MMarket Cap
LossP/E TTM
Lexeo Therapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-1.86
39.76%
Analyst Rating
STRONG BUY
2026-07-04
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Lexeo Therapeutics Inc?
According to Lexeo Therapeutics Inc's FY2025 earnings report, its current assets were 188.39M, with a year-on-year change of 49.37.
What are the total assets of Lexeo Therapeutics Inc?
According to Lexeo Therapeutics Inc's FY2025 earnings report, its total assets of Lexeo Therapeutics Inc were 268.69M, with a year-on-year change of 82.85.
What are the total liabilities of Lexeo Therapeutics Inc?
According to Lexeo Therapeutics Inc's FY2025 earnings report, its total liabilities of Lexeo Therapeutics Inc were 22.02M, with a year-on-year change of -26.85.
What is the total equity of Lexeo Therapeutics Inc?
According to Lexeo Therapeutics Inc's FY2025 earnings report, its total equity of Lexeo Therapeutics Inc was 246.67M, with a year-on-year change of 111.11.
What is the net investment of Lexeo Therapeutics Inc?
According to Lexeo Therapeutics Inc's FY2025 earnings report, its net investment of Lexeo Therapeutics Inc was -90.25M, with a year-on-year change of 4.07.
What is the net financing of Lexeo Therapeutics Inc?
According to Lexeo Therapeutics Inc's FY2025 earnings report, its net financing of Lexeo Therapeutics Inc was 216.79M, with a year-on-year change of 144.20.
What is the Earnings Per Share (EPS) of Lexeo Therapeutics Inc?
According to Lexeo Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.86, with a year-on-year change of 39.76.
What is the debt-to-asset ratio of Lexeo Therapeutics Inc?
According to Lexeo Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 0.31, with a year-on-year change of -66.68.
What is the Return on Equity (ROE) of Lexeo Therapeutics Inc?
According to Lexeo Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -55.00, with a year-on-year change of 35.58.
What is the Return on Assets (ROA) of Lexeo Therapeutics Inc?
According to Lexeo Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -48.10, with a year-on-year change of 29.87.
What is the operating profit of Lexeo Therapeutics Inc?
According to Lexeo Therapeutics Inc's FY2025 earnings report, its operating profit was -109.26M, with a year-on-year change of -3.30.